跳至主要内容
临床试验/JPRN-UMIN000008633
JPRN-UMIN000008633已完成4 期

A Phase 4 clinical trial of EMPYNASE P tablets 18000 in patients with chronic sinusitis - A Phase 4 clinical trial of EMPYNASE P tablets 18000 in patients with chronic sinusitis

KAKEN PHARMACEUTICAL CO., LTD.0 个研究点目标入组 260 人开始时间: 2012年8月6日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
260

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • -Patients with nasal polyp of score 2 or 3 -Patients diagnosed as eosinophilic sinusitis by the principal investigator or sub-investigator -Patients with complication such as maxillary sinusitis of dental origin, caseous maxillary sinusitis, sinus syst or asthma including aspirin-induced asthma -Patients with symptoms of acute sinusitis or acute exacerbation -Patients with pollinosis ( seasonal allergic rhinitis ), and term of causative pollen dispersal -Patients who have or are suspected to have sinus mycosis -Patients who have undergone operation of maxillary sinus, endoscopic sinus surgery or nasal polyplectomy, however patients underwent nasal polyplectomy before 3 months or more are excepted -Patients treated with the prohibited medication or therapy within 2 weeks

研究者

相似试验